UCFA
MNTA

United Capital Financial Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

United Capital Financial Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11,523
Closed -$201K – 1321
2015
Q1 		$201K Buy
+11,523
New +$150K ﹤0.01% 1184

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

United Capital Financial Advisors's MNTA Position: Q2 2015 in Review

United Capital Financial Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2015, closing a stake of 11,523 shares — an estimated $201K sold.

United Capital Financial Advisors first reported a position in MNTA in Q1 2015 and held it in 1 quarter. The position peaked at $201K in Q1 2015. 162 funds tracked by Wall St. Rank hold MNTA as of Q2 2015.

  • United Capital Financial Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • United Capital Financial Advisors sold 11,523 Momenta Pharmaceuticals, Inc. shares in Q2 2015, an estimated $201K.
  • United Capital Financial Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • United Capital Financial Advisors's Momenta Pharmaceuticals, Inc. position peaked at $201K in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2015.

Based on United Capital Financial Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.